Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli

International Journal of Medical Microbiology

Volumn 299, Issue 2, 2009, Pages 109-119

  Hotz, Christian ^a   Fensterle, Joachim ^a,c   Goebel, Werner ^b   Meyer, Susanne R ^a   Kirchgraber, Gabriel ^a   Heisig, Martin ^a   Fürer, Andreas ^d   Dietrich, Guido ^d   Rapp, Ulf R ^a   Gentschev, Ivaylo ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Zentaris GmbH   (Germany)

^d Berna Biotech AG   (Switzerland)

Author keywords

Antigen; Escherichia coli hemolysin secretion system; Live bacterial vaccines; Salmonella typhi Ty21a; Vaccine carrier

Indexed keywords

HEMOLYSIN; LIVE VACCINE; SALMONELLA ENTERICA SEROVAR TYPHI STRAIN TY21A VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE; GENE MUTATION; GENETIC COMPLEMENTATION; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN SECRETION; RFAH GENE; RPOS GENE; SALMONELLA ENTERICA; SEROTYPE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; ESCHERICHIA COLI PROTEINS; GENETIC COMPLEMENTATION TEST; HEMOLYSIN PROTEINS; MICE; PEPTIDE ELONGATION FACTORS; PLASMIDS; SALMONELLA TYPHI; SIGMA FACTOR; TRANS-ACTIVATORS; VACCINES, ATTENUATED;

EID: 58649119812     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2008.06.006     Document Type: Article

References (43)

1. Alam M.S., Zaki M.H., Yoshitake J., Akuta T., Ezaki T., and Akaike T. Involvement of Salmonella enterica serovar Typhi RpoS in resistance to NO-mediated host defense against serovar Typhi infection. Microb. Pathog. 40 (2006) 116-125
2. Attridge S.R., Daniels D., Morona J.K., and Morona R. Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210. Microb. Pathog. 8 (1990) 177-188
3. Bittner M., Saldias S., Altamirano F., Valvano M.A., and Contreras I. RpoS and RpoN are involved in the growth-dependent regulation of rfaH transcription and O antigen expression in Salmonella enterica serovar Typhi. Microb. Pathog. 36 (2004) 19-24
4. Bumann D., Metzger W.G., Mansouri E., Palme O., Wendland M., Hurwitz R., Haas G., Aebischer T., von Specht B.U., and Meyer T.F. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20 (2001) 845-852
5. Chang A.C., and Cohen S.N. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134 (1978) 1141-1156
6. Coynault C., Robbe-Saule V., and Norel F. Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon. Mol. Microbiol. 22 (1996) 149-160
7. Donner, P., Goebel, W., Demuth, A., Gentschev, I., Hess, J., Kaufmann, S.H.E., 1998. Use of a secretion vector for fertility control by oral vaccination. Patent WO-09850067.
8. Fang F.C., Libby S.J., Buchmeier N.A., Loewen P.C., Switala J., Harwood J., and Guiney D.G. The alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc. Natl. Acad. Sci. USA 89 (1992) 11978-11982
9. Fensterle J., Bergmann B., Yone C.L., Hotz C., Meyer S.R., Spreng S., Goebel W., Rapp U.R., and Gentschev I. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B. Cancer Gene Ther. 15 (2008) 85-93
10. Fukasawa T., and Nikaido H. Galactose-sensitive mutants of Salmonella. II. Bacteriolysis induced by galactose. Biochim. Biophys. Acta 48 (1961) 470-483
11. Galen J.E., and Levine M.M. Can a 'flawless' live vector vaccine strain be engineered?. Trends Microbiol. 9 (2001) 372-376
12. Gentschev I., Maier G., Kranig A., and Goebel W. Mini-TnhlyAs: a new tool for the construction of secreted fusion proteins. Mol. Gen. Genet. 252 (1996) 266-274
13. Gentschev I., Mollenkopf H., Sokolovic Z., Hess J., Kaufmann S.H., and Goebel W. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene 179 (1996) 133-140
14. Gentschev I., Dietrich G., and Goebel W. The E. coli alpha-hemolysin secretion system and its use in vaccine development. Trends Microbiol. 10 (2002) 39-45
15. Gentschev I., Dietrich G., Spreng S., Pilgrim S., Stritzker J., Kolb-Maurer A., and Goebel W. Delivery of protein antigens and DNA by attenuated intracellular bacteria. Int. J. Med. Microbiol. 291 (2002) 577-582
16. Gentschev I., Dietrich G., Spreng S., Neuhaus B., Maier E., Benz R., Goebel W., Fensterle J., and Rapp U.R. Use of the alpha-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strain. Int. J. Med. Microbiol. 294 (2004) 363-371
17. Gentschev I., Fensterle J., Schmidt A., Potapenko T., Troppmair J., Goebel W., and Rapp U.R. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice. BMC Cancer 5 (2005) 15
18. Gentschev I., Spreng S., Sieber H., Ures J., Mollet F., Collioud A., Pearman J., Griot-Wenk M.E., Fensterle J., Rapp U.R., Goebel W., Rothen S.A., and Dietrich G. Vivotif - a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens. Chemotherapy 53 (2007) 177-180
19. Germanier R., and Furer E. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect. Immun. 4 (1971) 663-673
20. Germanier R., and Furer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131 (1975) 553-558
21. Germanier R., and Furer E. Characteristics of the attenuated oral vaccine strain 'S. typhi' Ty 21a. Dev. Biol. Stand. 53 (1983) 3-7
22. Hahn H.P., Hess C., Gabelsberger J., Domdey H., and von Specht B.U. A Salmonella typhimurium strain genetically engineered to secrete effectively a bioactive human interleukin (hIL)-6 via the Escherichia coli hemolysin secretion apparatus. FEMS Immunol. Med. Microbiol. 20 (1998) 111-119
23. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W., and Kaufmann S.H. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93 (1996) 1458-1463
24. Khan A.Q., Zhao L., Hirose K., Miyake M., Li T., Hashimoto Y., Kawamura Y., and Ezaki T. Salmonella typhi rpoS mutant is less cytotoxic than the parent strain but survives inside resting THP-1 macrophages. FEMS Microbiol. Lett. 161 (1998) 201-208
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Lee H.Y., Cho S.A., Lee I.S., Park J.H., Seok S.H., Baek M.W., Kim D.J., Lee S.H., Hur S.J., Ban S.J., Lee Y.K., Han Y.K., Cho Y.K., and Park J.H. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice. FEMS Immunol. Med. Microbiol. 51 (2007) 310-318
27. Leeds J.A., and Welch R.A. RfaH enhances elongation of Escherichia coli hlyCABD mRNA. J. Bacteriol. 178 (1996) 1850-1857
28. Leeds J.A., and Welch R.A. Enhancing transcription through the Escherichia coli hemolysin operon, hlyCABD: RfaH and upstream JUMPStart DNA sequences function together via a postinitiation mechanism. J. Bacteriol. 179 (1997) 3519-3527
29. Metzger W.G., Mansouri E., Kronawitter M., Diescher S., Soerensen M., Hurwitz R., Bumann D., Aebischer T., Von Specht B.U., and Meyer T.F. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 22 (2004) 2273-2277
30. Nagy G., Dobrindt U., Hacker J., and Emody L. Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice. Infect. Immun. 72 (2004) 4297-4301
31. Nagy G., Danino V., Dobrindt U., Pallen M., Chaudhuri R., Emody L., Hinton J.C., and Hacker J. Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate. Infect. Immun. 74 (2006) 5914-5925
32. Nickerson C.A., and Curtiss III R. Role of sigma factor RpoS in initial stages of Salmonella typhimurium infection. Infect. Immun. 65 (1997) 1814-1823
33. Robbe-Saule V., Coynault C., and Norel F. The live oral typhoid vaccine Ty21a is a rpoS mutant and is susceptible to various environmental stresses. FEMS Microbiol. Lett. 126 (1995) 171-176
34. Robbe-Saule V., Algorta G., Rouilhac I., and Norel F. Characterization of the RpoS status of clinical isolates of Salmonella enterica. Appl. Environ. Microbiol. 69 (2003) 4352-4358
35. Rojas G., Saldias S., Bittner M., Zaldivar M., and Contreras I. The rfaH gene, which affects lipopolysaccharide synthesis in Salmonella enterica serovar Typhi, is differentially expressed during the bacterial growth phase. FEMS Microbiol. Lett. 204 (2001) 123-128
36. Rüssmann H., Shams H., Poblete F., Fu Y., Galan J.E., and Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281 (1998) 565-568
37. Spreng S., Dietrich G., Goebel W., and Gentschev I. The Escherichia coli haemolysin secretion apparatus: a potential universal antigen delivery system in gram-negative bacterial vaccine carriers. Mol. Microbiol. 31 (1999) 1596-1598
38. Spreng S., Dietrich G., Goebel W., and Gentschev I. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing protective listerial epitopes within a surface-exposed loop of the TolC-protein. Vaccine 21 (2003) 746-752
39. Vogel M., Hess J., Then I., Juarez A., and Goebel W. Characterization of a sequence (hlyR) which enhances synthesis and secretion of hemolysin in Escherichia coli. Mol. Gen. Genet. 212 (1988) 76-84
40. Wandersman C., and Delepelaire P. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc. Natl. Acad. Sci. USA 87 (1990) 4776-4780
41. Warburg O., and Christian W. Isolierung und Kristallisation des Gärungsferments Enolase. Biochem. Z. 310 (1942) 384-421
42. Westphal O., Lüderitz O., and Bister F. Über die Extraktion von Bakterien mit Phenol-Wasser. Z. Naturforsch. 7 (1952) 148-155
43. Wick M.J., Harding C.V., Twesten N.J., Normark S.J., and Pfeifer J.D. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol. Microbiol. 16 (1995) 465-476